SUBSCRIBERS
Is there a need for Ardmore Medical to rush out its IPO?
Published Mon, Jul 8, 2019 · 09:50 PM
SURGERIES are delicate procedures, never without risk. So are initial public offerings (IPOs).
The doctors at Ardmore Medical Group, which specialises in orthopaedic surgery, aesthetics and pain management, are planning an IPO on the Catalist board.
Investors should study the risk factors listed in Ardmore's offer document before they take a punt.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Singapore-based Princeton Digital gets green loan for US$1.5 billion Asia AI hub
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Apple is working on its own AI chip for data centres: WSJ
European oil giants consider shifting their listings to the US
ExxonMobil sees Hess arbitration dragging into 2025, CEO says
Gold prices tick higher on US rate cut bets